RxDoctor Payments Data

Andres Smith, MD

Emergency Medicine · Chula Vista, CANPI 1548270200

Payments from drug & device makers

$20,478in general payments, 2019–2025

Across 68 payments — averaging $301.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$17K
  • Inari Medical, Inc.$792
  • Biotronik Inc.$425
  • Abbott$420
  • Johnson & Johnson$364
  • Edwards Lifesciences$195
  • plus $843 from 12 others

What the payments were for

  • Speaking & faculty fees$14,90073%
  • Travel & lodging$6053%
  • Food & beverage$4,97324%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,478 in reported general payments places this provider in the 95th percentile of 6,006 emergency medicine providers in California.

See all emergency medicine providers in California

Medicare billing

Part B allowed, 2024
$58,862
Medicare patients
369
Services billed
710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin71$40,306
XareltoRivaroxaban71$40,007
Diclofenac Sodium21$31,920
VascepaIcosapent Ethyl64$18,466
OzempicSemaglutide11$14,293
EliquisApixaban18$11,038
Breo ElliptaFluticasone/Vilanterol11$4,443
Icosapent Ethyl20$2,657
Atorvastatin Calcium271$1,902
Levothyroxine Sodium150$1,484
Ezetimibe105$1,383
Ventolin HfaAlbuterol Sulfate23$1,335
Memantine Hcl19$1,269
Risperidone OdtRisperidone13$1,251
Albuterol Sulfate HfaAlbuterol Sulfate35$1,209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$364$40,00771 claims
Novo NordiskOzempic$146$14,29311 claims
PfizerEliquis$133$11,03818 claims
Lilly USA, LLCOlanzapine$45$67914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,006 emergency medicine providers in California.

Other emergency medicine in Chula Vista

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →